1 |1 | Countries using and planning to introduce IPV

2 |2 | Countries using and planning to introduce IPV August 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this Definitions Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat. Intent to introduce*: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to GAVI, or by requesting technical assistance to develop an IPV introduction plan. Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan. *NB. From 3 August 2015, all countries were categorized as either having introduced IPV or formally committed to introducing according to the Polio Endgame timelines.

3 |3 | Countries using IPV vaccine to date and formal decision to introduce Data source: WHO/IVB Database, as of 03 August 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 3 August 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(97 countries or 50%) Formal commitment to introduce in 2015 (74 countries or 38.1%) Intend to introduce in 2015(0 country or 0%) Formal commitment to introduce in 2016(23 countries or 11.9%) Not available Not applicable Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015) *NB. From 3 August 2015, all countries were categorized as either having introduced IPV or formally committed to introducing according to the Polio Endgame timelines. * Includes introductions in some parts of the country only

4 |4 | Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status Data source: WHO/IVB Database, as of 03 August 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 3 August 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(97 countries or 50%) Gavi countries with formal commitment to introduce in (55 countries or 28.4%) Non Gavi countries with formal commitment to introduce in (42 countries or 21.6%) Not available Not applicable Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015) * Includes introductions in some parts of the country only

5 |5 | 97 countries introducing IPV between 06 August 2015 and June 2016 Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Source: WHO/UNICEF database as at 03 August 2015 Bahamas – Chile – Lesotho – Mauritius – Morocco and Yemen are introducing in 2015 but no month of introduction available.

6 |6 | Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Data source: WHO/IVB Database, as of 03 August 2015, based on 35 tier 1 & 2 countries Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 3 August 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduction* to date (27 countries or 77.1%) Formal commitment to introduce in 2015 (8 countries or 22.9%) Not applicable or not Tier 1 or 2 countries(159 countries or 82%) Since January 2013, the following Tier 1 and 2 countries have introduced IPV: The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015) * Includes introductions in some parts of the country only

7 |7 | Middle Income Countries using IPV vaccine to date and formal decision to introduce Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); Côte d'Ivoire, Kiribati, St Vincent & the Grenadines, and Sudan (June 2015); Bhutan, Cameroon, Pakistan and Sri Lanka (July 2015) Data source: WHO/IVB Database, as of 03 August 2015 based on 101 middle income countries (MIC) as per last World Bank classification (July 2015) Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 3 August 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(40 countries or 39.5%) Formal commitment to introduce in 2015 (50 countries or 49.5%) Formal commitment to introduce in 2016 (11 countries or 11%) Not Available / Not applicable/ Non MIC countries * Includes introductions in some parts of the country only

8 |8 | IPV introduction status and planned introduction by quarter by the end of 2015 status report Data source: WHO/IVB Database, as of 03 August 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 3 August 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(97 countries or 50%) Introduction planned in Q3 2015(25 countries or 12.9%) Introduction planned in Q4 2015(43 countries or 22.2%) Introduction planned in 2016 or planned in 2015 but month of introduction not known (29 countries or 14.9%) Not available Not applicable Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Kiribati, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan & Sri Lanka (July 2015) * Includes introductions in some parts of the country only